Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Radiology

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00330-016-4692-9PMID 27975145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.

  2015cited by this paper
• Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.

  2015cited by this paper
• Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium

  2015cited by this paper
• Functional polarization of tumour-associated macrophages by tumour-derived lactic acid

  2014cited by this paper
• A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.

  2014cited by this paper
• Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging

  2014cited by this paper
• Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment

  2014cited by this paper
• Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.

  2014cited by this paper
• Glioma: Application of Histogram Analysis of Pharmacokinetic Parameters from T1-Weighted Dynamic Contrast-Enhanced MR Imaging to Tumor Grading

  2014cited by this paper
• Tumor-associated macrophages: from mechanisms to therapy.

  2014cited by this paper
• Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology.

  2014cited by this paper
• Deciphering and reversing tumor immune suppression.

  2013cited by this paper
• Usefulness of FMISO—PET for Glioma Analysis

  2013cited by this paper
• Accessories to the crime: functions of cells recruited to the tumor microenvironment.

  2012cited by this paper
• Molecular Pathways Molecular Pathways : Hypoxia Response in Immune Cells Fighting or Promoting Cancer

  2012cited by this paper
• Dynamic contrast‐enhanced‐MRI of tumor hypoxia

  2012cited by this paper
• Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

  2012cited by this paper
• Coordinated regulation of myeloid cells by tumours

  2012cited by this paper
• Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging.

  2012cited by this paper
• Targeting hypoxia in cancer therapy

  2011cited by this paper
• 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma

  2011cited by this paper
• HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

  2011cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

  2010cited by this paper
• Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

  2010cited by this paper
• THE CORRELATION AND PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION AND MGMT PROTEIN IN GLIOBLASTOMAS

  2009cited by this paper
• Non-invasive assessment of tumor neovasculature: techniques and clinical applications

  2008cited by this paper
• Molecular Imaging of Hypoxia

  2008cited by this paper
• New algorithm for quantifying vascular changes in dynamic contrast‐enhanced MRI independent of absolute T1 values

  2007cited by this paper
• Robust Computation of Mutual Information Using Spatially Adaptive Meshes

  2007cited by this paper
• Blood–brain barrier and chemotherapeutic treatment of brain tumors

  2006cited by this paper
• Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Comparative study of methods for determining vascular permeability and blood volume in human gliomas

  2004cited by this paper
• A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas

  2004cited by this paper
• Mutual-information-based registration of medical images: a survey

  2003cited by this paper
• Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix.

  2000cited by this paper
• Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols

  1999cited by this paper
• Concepts of oxygen transport at the microcirculatory level.

  1998cited by this paper
• Tumor oxygenation: a matter of supply and demand.

  1996cited by this paper
• Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts

  1991cited by this paper
• A proposal for examining and reporting stepwise regressions.

  1991cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper

• Predicting progression of enhancing non-measurable disease in high-grade glioma by using dynamic contrast-enhanced MR imaging.

  2025cites this paper
• Correlation of Ktrans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy

  2024cites this paper
• Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma

  2024influential citation
• PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma

  2024cites this paper
• Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype

  2023cites this paper
• Exploratory Analysis of Serial 18F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma

  2022cites this paper
• Multimodal imaging of brain tumors

  2022influential citation
• Tumor Progression and Treatment-Related Changes: Radiological Diagnosis Challenges for the Evaluation of Post Treated Glioma

  2022cites this paper
• The Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in the Differentiation of Pseudoprogression and Recurrence of Intracranial Gliomas

  2022cites this paper
• Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review

  2022cites this paper
• Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma

  2021cites this paper
• MGMT Promoter Methylation Status in Initial and Recurrent Glioblastoma: Correlation Study with DWI and DSC PWI Features

  2021cites this paper
• Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI

  2021cites this paper
• Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI

  2021cites this paper
• How tissue T1-variability influences DCE-MRI perfusion parameters estimation of recurrent high-grade glioma after surgery followed by radiochemotherapy

  2021cites this paper
• Assessing the reproducibility of high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging in patients with gliomas

  2021cites this paper
• Prognostication of anaplastic astrocytoma patients: application of contrast leakage information of dynamic susceptibility contrast-enhanced MRI and dynamic contrast-enhanced MRI

  2020cites this paper
• Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma

  2020cites this paper
• Advanced magnetic resonance imaging to support clinical drug development for malignant glioma.

  2020cites this paper
• Prediction of Recurrence Patterns in Glioblastoma Using DSC-MRI Radiomics-Based Deep Learning

  2020cites this paper
• Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value

  2019cites this paper
• Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders

  2019cites this paper
• Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas

  2019cites this paper
• The Role of Standard and Advanced Imaging for the Management of Brain Malignancies From a Radiation Oncology Standpoint.

  2018cites this paper
• Imaging in neuro-oncology

  2018cites this paper
• Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques

  2018cites this paper
• Magnetic Resonance Perfusion Imaging in the Diagnosis of High-Grade Glioma Progression and Treatment-Related Changes: A Systematic Review

  2018influential citation
• Prediction value of unmeasurable MR enhancement at early stage after gross-total resection on the survival state of patients with high-grade glioma

  2018cites this paper
• The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.

  2018influential citation
• T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients

  2017cites this paper
• Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.

  2017cites this paper
• FeaturesCorrelation Study with DWI and DSC PWI Initial and Recurrent Glioblastoma: Promoter Methylation Status in MGMT

  year unknowncites this paper